|
|
|
Volumn 33, Issue 1, 1996, Pages 24-42
|
|
Reactivation of fetal hemoglobin in patients with β-thalassemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 PHENYLBUTYRATE SODIUM;
ARGININE BUTYRATE;
AZACITIDINE;
BUTYRIC ACID DERIVATIVE;
CHELATING AGENT;
CYTARABINE;
DEFEROXAMINE MESYLATE;
GROWTH FACTOR;
HEMOGLOBIN F;
HYDROXYUREA;
ISOBUTYRAMIDE;
POTASSIUM;
RECOMBINANT ERYTHROPOIETIN;
SHORT CHAIN FATTY ACID;
UNCLASSIFIED DRUG;
VALPROIC ACID;
VINBLASTINE;
ADULT;
ANIMAL CELL;
ANIMAL MODEL;
BETA THALASSEMIA;
BLOOD TRANSFUSION;
BONE MARROW SUPPRESSION;
BONE PAIN;
CASE REPORT;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
ERYTHROPOIESIS;
FEMALE;
GASTROINTESTINAL TOXICITY;
GENE EXPRESSION REGULATION;
GRAND MAL SEIZURE;
HEMOGLOBIN SYNTHESIS;
HUMAN;
HYPOKALEMIA;
INTRAVENOUS DRUG ADMINISTRATION;
IRON CHELATION;
IRON OVERLOAD;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
NEUROTOXICITY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
VOMITING;
AZACITIDINE;
BETA-THALASSEMIA;
BUTYRIC ACID;
BUTYRIC ACIDS;
ERYTHROPOIETIN;
FETAL HEMOGLOBIN;
HOMOZYGOTE;
HUMANS;
HYDROXYUREA;
TREATMENT OUTCOME;
|
|
EID: 0030039970
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (67)
|
|
References (0)
|
